GR1004193B - Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη - Google Patents

Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη

Info

Publication number
GR1004193B
GR1004193B GR20010100377A GR2001100377A GR1004193B GR 1004193 B GR1004193 B GR 1004193B GR 20010100377 A GR20010100377 A GR 20010100377A GR 2001100377 A GR2001100377 A GR 2001100377A GR 1004193 B GR1004193 B GR 1004193B
Authority
GR
Greece
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Application number
GR20010100377A
Other languages
Greek (el)
English (en)
Other versions
GR20010100377A (el
Inventor
Per Holm
Ken Liljegren
Ole Nielsen
Swen Wagner
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR1004193(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of GR20010100377A publication Critical patent/GR20010100377A/el
Publication of GR1004193B publication Critical patent/GR1004193B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR20010100377A 2000-08-10 2001-07-31 Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη GR1004193B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
GR20010100377A GR20010100377A (el) 2002-09-06
GR1004193B true GR1004193B (el) 2003-03-24

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100377A GR1004193B (el) 2000-08-10 2001-07-31 Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη

Country Status (34)

Country Link
EP (1) EP1318805A2 (ja)
JP (1) JP2003531153A (ja)
KR (1) KR20030024833A (ja)
CN (1) CN1446089A (ja)
AR (1) AR030095A1 (ja)
AT (1) AT5744U1 (ja)
AU (2) AU2001100198B4 (ja)
BE (1) BE1013559A6 (ja)
BG (1) BG107578A (ja)
BR (1) BR0113250A (ja)
CA (1) CA2353693C (ja)
CH (2) CH694241A5 (ja)
CZ (1) CZ2003397A3 (ja)
DE (2) DE10139115A1 (ja)
EA (1) EA200300247A1 (ja)
ES (1) ES2172481B2 (ja)
FI (1) FI5176U1 (ja)
FR (1) FR2812811B1 (ja)
GB (1) GB2368014B (ja)
GR (1) GR1004193B (ja)
HR (1) HRP20030054A2 (ja)
HU (1) HUP0103071A3 (ja)
IE (1) IES20010693A2 (ja)
IL (1) IL154050A0 (ja)
IS (1) IS6021A (ja)
IT (1) ITMI20011637A1 (ja)
MX (1) MXPA03000837A (ja)
NL (1) NL1018741C1 (ja)
NO (1) NO20013891L (ja)
NZ (1) NZ523785A (ja)
PL (1) PL359824A1 (ja)
SK (1) SK2842003A3 (ja)
WO (1) WO2001080619A2 (ja)
YU (1) YU9003A (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
PT1578738E (pt) * 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form
WO2024165628A1 (en) 2023-02-07 2024-08-15 Kinast Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
ES2172481B2 (es) 2004-08-01
GB2368014A (en) 2002-04-24
HUP0103071A3 (en) 2002-12-28
EA200300247A1 (ru) 2003-06-26
FR2812811A1 (fr) 2002-02-15
HRP20030054A2 (en) 2005-02-28
GR20010100377A (el) 2002-09-06
MXPA03000837A (es) 2003-06-06
NL1018741C1 (nl) 2002-02-12
JP2003531153A (ja) 2003-10-21
IES20010693A2 (en) 2002-07-10
CZ2003397A3 (cs) 2003-06-18
WO2001080619A2 (en) 2001-11-01
SK2842003A3 (en) 2003-09-11
DE20113195U1 (de) 2001-11-15
BG107578A (bg) 2003-09-30
HU0103071D0 (en) 2001-10-28
EP1318805A2 (en) 2003-06-18
KR20030024833A (ko) 2003-03-26
BE1013559A6 (fr) 2002-03-05
YU9003A (sh) 2006-05-25
FI5176U1 (fi) 2001-12-27
PL359824A1 (en) 2004-09-06
AU2001100198B4 (en) 2002-06-13
CN1446089A (zh) 2003-10-01
ITMI20011637A1 (it) 2003-01-27
BR0113250A (pt) 2003-06-24
GB2368014B (en) 2004-06-23
IL154050A0 (en) 2003-07-31
CA2353693C (en) 2003-07-22
CH694242A5 (de) 2004-10-15
AU2001100198A4 (en) 2001-08-16
IS6021A (is) 2001-10-20
ES2172481A1 (es) 2002-09-16
HUP0103071A2 (hu) 2002-05-29
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
DE10139115A1 (de) 2002-03-28
ITMI20011637A0 (it) 2001-07-27
NO20013891L (no) 2002-02-11
CH694241A5 (de) 2004-10-15
AU2001279591A1 (en) 2001-11-07
NO20013891D0 (no) 2001-08-09
AR030095A1 (es) 2003-08-13
AT5744U1 (de) 2002-11-25
FR2812811B1 (fr) 2006-08-18
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
GR1004193B (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
YU21999A (sh) Farmaceutske smese i postupak za njihovo dobijanje
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
TW200509905A (en) Pharmaceutical compositions of atorvastatin
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
AP2003002763A0 (en) Controlled release formulations for oral administration
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
RU2003100507A (ru) Фармацевтические композиции
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
TW200517127A (en) Novel composition
YU54503A (sh) Farmaceutski sastav koji sadrži citalopram
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
TW200500085A (en) Sustained-release pharmaceutical composition for lung administration
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
GB9917290D0 (en) Pharmaceutical composition
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon